Refine
Year of publication
- 2019 (1165) (remove)
Document Type
- Journal article (608)
- Doctoral Thesis (415)
- Complete part of issue (51)
- Book article / Book chapter (33)
- Preprint (19)
- Book (13)
- Working Paper (8)
- Master Thesis (4)
- Report (3)
- Study Thesis (term paper) (3)
Language
- English (798)
- German (363)
- Multiple languages (2)
- Russian (1)
- Spanish (1)
Keywords
- Universität (47)
- Wuerzburg (47)
- Würzburg (47)
- University (46)
- Wurzburg (46)
- Animal Studies (24)
- Cultural Animal Studies (24)
- Cultural Studies (24)
- Ecocriticism (24)
- Environmental Humanities (24)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (123)
- Graduate School of Life Sciences (69)
- Physikalisches Institut (56)
- Medizinische Klinik und Poliklinik II (50)
- Medizinische Klinik und Poliklinik I (48)
- Universität - Fakultätsübergreifend (46)
- Institut für Anorganische Chemie (41)
- Neurologische Klinik und Poliklinik (40)
- Institut für deutsche Philologie (39)
- Institut für Organische Chemie (37)
- Institut für Psychologie (37)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (35)
- Neuphilologisches Institut - Moderne Fremdsprachen (33)
- Kinderklinik und Poliklinik (32)
- Institut für Geographie und Geologie (30)
- Rudolf-Virchow-Zentrum (27)
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (25)
- Institut für Pharmazie und Lebensmittelchemie (25)
- Institut für Hygiene und Mikrobiologie (24)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (24)
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (24)
- Institut für Virologie und Immunbiologie (23)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (22)
- Julius-von-Sachs-Institut für Biowissenschaften (20)
- Institut für Informatik (18)
- Institut für Theoretische Physik und Astrophysik (18)
- Lehrstuhl für Orthopädie (18)
- Pathologisches Institut (18)
- Institut für Physikalische und Theoretische Chemie (17)
- Institut für Molekulare Infektionsbiologie (16)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (15)
- Klinik und Poliklinik für Strahlentherapie (15)
- Betriebswirtschaftliches Institut (14)
- Klinik und Poliklinik für Nuklearmedizin (14)
- Klinik und Poliklinik für Unfall-, Hand-, Plastische und Wiederherstellungschirurgie (Chirurgische Klinik II) (14)
- Institut für Klinische Epidemiologie und Biometrie (13)
- Institut für Pharmakologie und Toxikologie (13)
- Institut für Humangenetik (12)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (12)
- Institut für Anatomie und Zellbiologie (11)
- Institut für Experimentelle Biomedizin (11)
- Institut für Funktionsmaterialien und Biofabrikation (11)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (11)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (11)
- Medizinische Fakultät (11)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (10)
- Neurochirurgische Klinik und Poliklinik (10)
- Comprehensive Cancer Center Mainfranken (9)
- Institut für Klinische Neurobiologie (9)
- Institut für Mathematik (8)
- Institut für Politikwissenschaft und Soziologie (8)
- Institut für Sportwissenschaft (8)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (8)
- Abteilung für Molekulare Innere Medizin (in der Medizinischen Klinik und Poliklinik II) (7)
- Graduate School of Science and Technology (7)
- Institut Mensch - Computer - Medien (7)
- Institut für Geschichte der Medizin (7)
- Klinik und Poliklinik für Mund-, Kiefer- und Plastische Gesichtschirurgie (7)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (7)
- Augenklinik und Poliklinik (5)
- Fakultät für Biologie (5)
- Frauenklinik und Poliklinik (5)
- Institut für Altertumswissenschaften (5)
- Lehrstuhl für Biochemie (5)
- Universität Würzburg (5)
- Fakultät für Humanwissenschaften (Philos., Psycho., Erziehungs- u. Gesell.-Wissensch.) (4)
- Institut für Geschichte (4)
- Institut für Psychotherapie und Medizinische Psychologie (4)
- Institut für Systemimmunologie (4)
- Lehrstuhl für Molekulare Psychiatrie (4)
- Philosophische Fakultät (Histor., philolog., Kultur- und geograph. Wissensch.) (4)
- Sportzentrum (4)
- Urologische Klinik und Poliklinik (4)
- Volkswirtschaftliches Institut (4)
- Institut für Biblische Theologie (3)
- Institut für Internationales Recht, Europarecht und Europäisches Privatrecht (3)
- Institut für Kulturwissenschaften Ost- und Südasiens (3)
- Institut für Musikforschung (3)
- Physiologisches Institut (3)
- Abteilung für Parodontologie (in der Poliklinik für Zahnerhaltung und Parodontologie) (2)
- Center for Computational and Theoretical Biology (2)
- Institut für Klinische Transfusionsmedizin und Hämotherapie (2)
- Institut für Medizinische Strahlenkunde und Zellforschung (2)
- Institut für Pädagogik (2)
- Institut für Sonderpädagogik (2)
- Klinik und Polikliniken für Zahn-, Mund- und Kieferkrankheiten (2)
- Missionsärztliche Klinik (2)
- Poliklinik für Zahnerhaltung und Parodontologie (2)
- Abteilung für Forensische Psychiatrie (1)
- Institut für Allgemeinmedizin (1)
- Institut für Archäologie (1)
- Institut für Bürgerliches Recht und Zivilprozessrecht (1)
- Institut für Kunstgeschichte (1)
- Institut für Philosophie (1)
- Institut für Praktische Theologie (1)
- Institut für Rechtsmedizin (1)
- Institut für Slavistik (1)
- Institut für Strafrecht und Kriminologie (1)
- Martin-von-Wagner-Museum (1)
- Poliklinik für Kieferorthopädie (1)
- Rechenzentrum (1)
- Universitätsbibliothek (1)
Schriftenreihe
Sonstige beteiligte Institutionen
- VolkswagenStiftung (24)
- DFG Forschungsgruppe 2757 / Lokale Selbstregelungen im Kontext schwacher Staatlichkeit in Antike und Moderne (LoSAM) (2)
- Deutsches Archäologisches Institut (2)
- Johns Hopkins School of Medicine (2)
- Universität Bayreuth (2)
- Universität Leipzig (2)
- Akademie der Wissenschaften und der Literatur, Mainz (1)
- Bio-Imaging Center Würzburg (1)
- CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - the development agency of the Brazilian Federal Government (1)
- Center for Nanosystems Chemistry (CNC), Universität Würzburg (1)
ResearcherID
- B-4606-2017 (1)
EU-Project number / Contract (GA) number
- 669054 (8)
- 602805 (6)
- 646737 (5)
- 728018 (5)
- 614623 (3)
- 309962 (2)
- 615613 (2)
- 617989 (2)
- 669830 (2)
- 682586 (2)
- 701983 (2)
- 715923 (2)
- 206726 (1)
- 223175 (1)
- 230331-PROPEREMO (1)
- 250194 (1)
- 281338 (1)
- 307701 (1)
- 336012 (1)
- 336305 (1)
- 607051 (1)
- 609409 (1)
- 610028 (1)
- 617198 (1)
- 633784 (1)
- 633983-2 (1)
- 634935 (1)
- 654148 (1)
- 677020 (1)
- 677749 (1)
- 677819 (1)
- 678119 (1)
- 683083 (1)
- 686070 (1)
- 707362 (1)
- 714087 (1)
- 715466 (1)
- 715890 (1)
- 725229 (1)
- 725832 (1)
- 772376 (1)
- 819329 (1)
- EU250194 (1)
RsaE is a conserved small regulatory RNA (sRNA) which was previously reported to represent a riboregulator of central carbon flow and other metabolic pathways in Staphylococcus aureus and Bacillus subtilis. Here we show that RsaE contributes to extracellular (e)DNA release and biofilm-matrix switching towards polysaccharide intercellular adhesin (PIA) production in a hypervariable Staphylococcus epidermidis isolate. Transcriptome analysis through differential RNA sequencing (dRNA-seq) in combination with confocal laser scanning microscopy (CLSM) and reporter gene fusions demonstrate that S. epidermidis protein- and PIA-biofilm matrix producers differ with respect to RsaE and metabolic gene expression. RsaE is spatiotemporally expressed within S. epidermidis PIA-mediated biofilms, and its overexpression triggers a PIA biofilm phenotype as well as eDNA release in an S. epidermidis protein biofilm matrix-producing strain background. dRNA-seq and Northern blot analyses revealed RsaE to exist as a major full-length 100-nt transcript and a minor processed species lacking approximately 20 nucleotides at the 5'-end. RsaE processing results in expansion of the mRNA target spectrum. Thus, full-length RsaE interacts with S. epidermidis antiholin-encoding lrgA mRNA, facilitating bacterial lysis and eDNA release. Processed RsaE, however, interacts with the 5'-UTR of icaR and sucCD mRNAs, encoding the icaADBC biofilm operon repressor IcaR and succinyl-CoA synthetase of the tricarboxylic acid (TCA) cycle, respectively. RsaE augments PIA-mediated biofilm matrix production, most likely through activation of icaADBC operon expression via repression of icaR as well as by TCA cycle inhibition and re-programming of staphylococcal central carbon metabolism towards PIA precursor synthesis. Additionally, RsaE supports biofilm formation by mediating the release of eDNA as stabilizing biofilm matrix component. As RsaE itself is heterogeneously expressed within biofilms, we consider this sRNA to function as a factor favoring phenotypic heterogeneity and supporting division of labor in S. epidermidis biofilm communities.
Background
Persistent antiphospholipid antibodies (aPL) constitute the serological hallmark of the antiphospholipid syndrome (APS). Recently, various new assay technologies for the detection of aPL better suited to multiplex reaction environments than ELISAs emerged. We evaluated the diagnostic performance of such a novel line immunoassay (LIA) for the simultaneous detection of 10 different aPL.
Methods
Fifty-three APS patients and 34 healthy controls were investigated for criteria (antibodies against cardiolipin [aCL], β2-glycoprotein I [aβ2-GPI]) and non-criteria aPL (antibodies against phosphatidic acid [aPA], phosphatidyl-choline [aPC], -ethanolamine [aPE], -glycerol [aPG], -inositol [aPI], -serine [aPS], annexin V [aAnnV], prothrombin [aPT]) IgG and IgM by LIA. Criteria aPL were additionally determined with the established Alegria (ALE), AcuStar (ACU), UniCap (UNI), and AESKULISA (AES) systems and non-criteria aPL with the AES system. Diagnostic performance was evaluated with a gold standard for criteria aPL derived from the results of the four established assays via latent class analysis and with the clinical diagnosis as gold standard for non-criteria aPL.
Results
Assay performance of the LIA for criteria aPL was comparable to that of ALE, ACU, UNI, and AES. For non-criteria aPL, sensitivities of the LIA for aPA-, aPI-, aPS-IgG and aPA-IgM were significantly higher and for aPC-, aPE-, aAnnV-IgG and aPC- and aPE-IgM significantly lower than AES. Specificities did not differ significantly.
Conclusions
The LIA constitutes a valuable diagnostic tool for aPL profiling. It offers increased sensitivity for the detection of aPL against anionic phospholipids. In contrast, ELISAs exhibit strengths for the sensitive detection of aPL against neutral phospholipids.
Neuroendocrine cells communicate via neuropeptides to regulate behaviour and physiology. This study examines how STIM (Stromal Interacting Molecule), an ER-Ca2+ sensor required for Store-operated Ca2+ entry, regulates neuropeptides required for Drosophila development under nutrient restriction (NR). We find two STIM-regulated peptides, Corazonin and short Neuropeptide F, to be required for NR larvae to complete development. Further, a set of secretory DLP (Dorso lateral peptidergic) neurons which co -express both peptides was identified. Partial loss of dSTIM caused peptide accumulation in the DLPs, and reduced systemic Corazonin signalling. Upon NR, larval development correlated with increased peptide levels in the DLPs, which failed to occur when dSTIM was reduced. Comparison of systemic and cellular phenotypes associated with reduced dSTIM, with other cellular perturbations, along with genetic rescue experiments, suggested that dSTIM primarily compromises neuroendocrine function by interfering with neuropeptide release. Under chronic stimulation, dSTIM also appears to regulate neuropeptide synthesis.
In accordance with the Red Queen hypothesis, the lower genotypic diversity in clonally reproducing species should make them easier targets for pathogen infection, especially when closely related sexually reproducing species occur in close proximity. We analyzed two populations of clonal P. formosa and their sexual parental species P. mexicana by correlating individual parasite infection with overall and immune genotype. Our study revealed lower levels of overall genotypic diversity and marginally fewer MHC class I alleles in P. formosa individuals compared to sexually reproducing P. mexicana. Parasite load, however, differed only between field sites but not between species. We hypothesize that this might be due to slightly higher genotypic diversity in P. formosa at the innate immune system (toll like receptor 8) which is likely due to the species’ hybrid origin. In consequence, it appears that clonal individuals do not necessarily suffer a disadvantage compared to sexual individuals when fighting parasite infection.
Background
In this study based on the BRENDA data, we investigated the impact of endocrine ± chemotherapy for luminal A, nodal positive breast cancer on recurrence free (RFS) and overall survival (OS). In addition, we analysed if tumor size of luminal A breast cancer influences survival in patients with the same number of positive lymph nodes.
Methods
In this retrospective multi-centre cohort study data of 1376 nodal-positive patients with primary diagnosis of luminal A breast cancer during 2001–2008 were analysed. The results were stratified by therapy and adjusted by age, tumor size and number of affected lymph nodes.
Results
In our study population, patients had a good to excellent prognosis (5-year RFS: 91% and tumorspecific 5-year OS 96.5%). There was no significant difference in RFS stratified by patients with only endocrine therapy and with endocrine plus chemo-therapy. Patients with 1–3 affected lymph nodes had no significant differences in OS treated only with endocrine therapy or with endocrine plus chemotherapy, independent of tumor size. Patients with large tumors and more than 3 affected lymph nodes had a significant worse survival as compared to the small tumors. However, despite the worse prognosis of those, adjuvant chemotherapy failed in order to improve RFS.
Conclusions
According to our data, nodal positive patients with luminal A breast cancer have, if any, a limited benefit of adjuvant chemotherapy. Tumor size and nodal status seem to be of prognostic value in terms of survival, however both tumor size as well as nodal status were not predictive for a benefit of adjuvant chemotherapy.
Objectives
To investigate the prevalence of depressive symptoms in rheumatoid arthritis (RA) patients using two previously validated questionnaires in a large patient sample, and to evaluate depressive symptoms in the context of clinical characteristics (e.g. remission of disease) and patient-reported impact of disease.
Methods
In this cross-sectional study, the previously validated Patient Health Questionnaire (PHQ-9) and Beck-Depression Inventory II (BDI-II) were used to assess the extent of depressive symptoms in RA patients. Demographic background, RA disease activity score (DAS28), RA impact of disease (RAID) score, comorbidities, anti-rheumatic therapy and antidepressive treatment, were recorded. Cut-off values for depressive symptomatology were PHQ-9 ≥5 or BDI-II ≥14 for mild depressive symptoms or worse and PHQ-9 ≥ 10 or BDI-II ≥ 20 for moderate depressive symptoms or worse. Prevalence of depressive symptomatology was derived by frequency analysis while factors independently associated with depressive symptomatology were investigated by using multiple logistic regression analyses. Ethics committee approval was obtained, and all patients provided written informed consent before participation.
Results
In 1004 RA-patients (75.1% female, mean±SD age: 61.0±12.9 years, mean disease duration: 12.2±9.9 years, DAS28 (ESR): 2.5±1.2), the prevalence of depressive symptoms was 55.4% (mild or worse) and 22.8% (moderate or worse). Characteristics independently associated with depressive symptomatology were: age <60 years (OR = 1.78), RAID score >2 (OR = 10.54) and presence of chronic pain (OR = 3.25). Of patients classified as having depressive symptoms, only 11.7% were receiving anti-depressive therapy.
Conclusions
Mild and moderate depressive symptoms were common in RA patients according to validated tools. In routine clinical practice, screening for depression with corresponding follow-up procedures is as relevant as incorporating these results with patient-reported outcomes (e.g. symptom state), because the mere assessment of clinical disease activity does not sufficiently reflect the prevalence of depressive symptoms.
Clinical trial registration number
This study is registered in the Deutsches Register Klinischer Studien (DRKS00003231) and ClinicalTrials.gov (NCT02485483).
The two main collagen receptors on platelets, GPVI and integrin α2β1, play an important role for the recognition of exposed collagen at sites of vessel injury, which leads to platelet activation and subsequently stable thrombus formation. Both receptors are already expressed on megakaryocytes, the platelet forming cells within the bone marrow. Megakaryocytes are in permanent contact with collagen filaments in the marrow cavity and at the basal lamina of sinusoids without obvious preactivation. The role of both collagen receptors for megakaryocyte maturation and thrombopoiesis is still poorly understood. To investigate the function of both collagen receptors, we generated mice that are double deficient for Gp6 and Itga2. Flow cytometric analyses revealed that the deficiency of both receptors had no impact on platelet number and led to the expected lack in GPVI responsiveness. Integrin activation and degranulation ability was comparable to wildtype mice. By immunofluorescence microscopy, we could demonstrate that both wildtype and double-deficient megakaryocytes were overall normally distributed within the bone marrow. We found megakaryocyte count and size to be normal, the localization within the bone marrow, the degree of maturation, as well as their association to sinusoids were also unaltered. However, the contact of megakaryocytes to collagen type I filaments was decreased at sinusoids compared to wildtype mice, while the interaction to type IV collagen was unaffected. Our results imply that GPVI and α2β1 have no influence on the localization of megakaryocytes within the bone marrow, their association to the sinusoids or their maturation. The decreased contact of megakaryocytes to collagen type I might at least partially explain the unaltered platelet phenotype in these mice, since proplatelet formation is mediated by these receptors and their interaction to collagen. It is rather likely that other compensatory signaling pathways and receptors play a role that needs to be elucidated.
Although accepted agents in chorioamnionitis and preterm birth, the role of Ureaplasma species (spp.) in inflammation-driven morbidities of prematurity, including the development of bronchopulmonary dysplasia, remains controversial. To add to scarce in vitro data addressing the pro-inflammatory capacity of Ureaplasma spp., pulmonary epithelial-like A549 cells and human pulmonary microvascular endothelial cells (HPMEC) were incubated with Ureaplasma (U.) urealyticum, U. parvum, and Escherichia coli lipopolysaccharide (LPS). Ureaplasma isolates down-regulated caspase mRNA levels in A549 cells (caspase 8: p<0.001, 9: p<0.001, vs. broth), while increasing caspase protein expression, enzyme activity, and cell death in HPMEC (active caspase 3: p<0.05, caspase 8: p<0.05, active caspase 9: p<0.05, viability: p<0.05). LPS, contrarily, induced caspase mRNA expression in HPMEC (caspase 3: p<0.01, 4: p<0.001, 5: p<0.001, 8: p<0.001, vs. control), but not in A549 cells, and did not affect enzyme activity or protein levels in either cell line. LPS, but neither Ureaplasma isolate, enhanced mRNA expression of pro-inflammatory interleukin (IL)-6 in both A549 (p<0.05, vs. control) and HPMEC (p<0.001) as well as tumor necrosis factor-α (p<0.01), IL-1β (p<0.001), and IL-8 (p<0.05) in HPMEC. We are therefore the first to demonstrate a differential modulation of pulmonary caspases by Ureaplasma spp. in vitro. Ureaplasma-driven enhanced protein expression and activity of caspases in pulmonary endothelial cells result in cell death and may cause structural damage. Down-regulated caspase mRNA in pulmonary epithelial cells, contrarily, may indicate Ureaplasma-induced inhibition of apoptosis and prevent effective immune responses. Both may ultimately contribute to chronic Ureaplasma colonization and long-term pulmonary inflammation.
Golgi α-mannosidase II (GMII) is a glycoside hydrolase playing a crucial role in the N-glycosylation pathway. In various tumour cell lines, the distribution of N-linked sugars on the cell surface is modified and correlates with the progression of tumour metastasis. GMII therefore is a possible molecular target for anticancer agents. Here, we describe the identification of a non-competitive GMII inhibitor using computer-aided drug design methods including identification of a possible allosteric binding site, pharmacophore search and virtual screening.
Therapy of bilateral vocal fold paralysis: Real world data of an international multi-center registry
(2019)
Purpose
To collect data on diagnosis, treatment, patient’s management, and quality of life in patient with bilateral vocal fold paralysis (BVFP).
Methods
A retrospective, observational, multicenter registry study was performed. Medical records of 326 adults with permanent BVFP (median age: 61 years; 70% female, 60% after thyroid surgery) generated between 2010 and 2017.
Results
Median time between BVFP onset and inclusion was 1.2 years. Median post-treatment follow-up was 2 months (range: 0–42). Surgery was treatment of choice in 61.7% of the cases, with a 2-year revision rate of 32.4%. Prior to inclusion, 40.2% of the patients underwent at least one surgery. For tracheotomized patients, decannulation rate was 33.8%. Non-surgical treatments included voice therapy and botulinum toxin injection. Corticosteroid application was the most frequent treatment for post-treatment complications (18%; 1-month after surgery). Older age was an independent predictor for dyspnea (Hazard ratio [HR] = 1.041; CI = 1.005 to 1.079; p = 0.026) and the need for oxygen treatment (HR = 1.098; CI = 1.009 to 1.196; p = 0.031). Current alcohol consumption (HR = 2.565; CI = 1.232 to 5.342; p = 0.012) and a cancer-related etiology (HR = 4.767; CI = 1.615 to 14.067; p = 0.005) were independent factors of higher revision risk.
Conclusions
Surgery for BVFP is currently not standardized but highly variable. Postoperative and BVFP-related complications and revision surgery are frequent. Complications are linked to patients’ alcohol drinking habits and BVFP etiology. These results shall be confirmed by the upcoming evaluation of the prospective data of this registry.